MedAdvisor looks like an interesting comparison to 1ST based on its revenue profile...
FY16 Rev = $1.8m
FY17 Rev = $4.9m
FY18 Rev = $7.5m
The CAGR (c.50%, for FY17/18) is higher than 1ST group, but 1ST group's revenue is similar to MedAdvisor's revenue profile 1-2 years ago. MedAdvisor is also not currently profitable.
The market cap of MedAdvisor has grown to c.$50m! Which means it currently trades on PSR of c.6.5.
This is in comparison to 1ST group's market cap of c.$7m (PSR of c.2)...
GLTAH. DYOR.
Ann: Annual Report to shareholders, page-7
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add VFX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.58M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 2563135 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 1758191 | 3 |
View Market Depth
| Last trade - 16.12pm 27/09/2024 (20 minute delay) ? |
| VFX (ASX) Chart |
Day chart unavailable